当前位置:首页 - 行情中心 - 凯赛生物(688065) - 财务分析 - 现金流量表

凯赛生物

(688065)

  

流通市值:267.65亿  总市值:330.93亿
流通股本:5.83亿   总股本:7.21亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,270,298,508.981,547,545,586.91701,043,331.962,934,724,311.4
  收到的税费返还35,652,208.1313,277,594.433,227,370.8860,208,042.79
  收到其他与经营活动有关的现金296,376,807.09251,607,396.3940,493,663.64356,516,611.74
  经营活动现金流入小计2,602,327,524.21,812,430,577.73744,764,366.483,351,448,965.93
  购买商品、接受劳务支付的现金1,785,547,700.681,091,270,527.87471,745,419.751,696,480,052.07
  支付给职工以及为职工支付的现金210,153,884.56142,444,627.7974,582,687.95256,920,942.47
  支付的各项税费254,279,960.47175,328,990.1788,273,525.68289,353,736
  支付其他与经营活动有关的现金79,252,756.2564,072,576.5722,673,346.19287,764,902.97
  经营活动现金流出小计2,329,234,301.961,473,116,722.4657,274,979.572,530,519,633.51
  经营活动产生的现金流量净额平衡项目0-0.0100
  经营活动产生的现金流量净额273,093,222.24339,313,855.3287,489,386.91820,929,332.42
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额35,109,714.2910,023,958.2-20,252,268.74
  收到的其他与投资活动有关的现金2,308,152,943.99400,078,904.11--
  投资活动现金流入的平衡项目00-0
  投资活动现金流入小计2,343,262,658.28410,102,862.31-20,252,268.74
  购建固定资产、无形资产和其他长期资产支付的现金546,099,764.78358,235,109.6279,727,020.78843,313,170.45
  投资支付的现金25,500,00025,500,00025,500,000-
  支付其他与投资活动有关的现金3,214,564,276.561,500,000,000--
  投资活动现金流出小计3,786,164,041.341,883,735,109.6305,227,020.78843,313,170.45
  投资活动产生的现金流量净额-1,442,901,383.06-1,473,632,247.29-305,227,020.78-823,060,901.71
三、筹资活动产生的现金流量:
  吸收投资收到的现金5,967,224,993.635,967,224,993.635,914,724,993.63-
  其中:子公司吸收少数股东投资收到的现金52,500,00052,500,000--
  取得借款收到的现金515,727,619.61491,288,209.39378,897,583.321,692,844,092.04
  收到其他与筹资活动有关的现金---196,446,714.44
  筹资活动现金流入小计6,482,952,613.246,458,513,203.026,293,622,576.951,889,290,806.48
  偿还债务支付的现金2,106,653,701.051,806,653,701.05615,493,8001,570,030,601.4
  分配股利、利润或偿付利息支付的现金303,675,702.4615,124,217.1912,871,162.17140,834,553.68
  支付其他与筹资活动有关的现金502,327.02502,327.02-28,933,667.53
  筹资活动现金流出小计2,410,831,730.531,822,280,245.26628,364,962.171,739,798,822.61
  筹资活动产生的现金流量净额4,072,120,882.714,636,232,957.765,665,257,614.78149,491,983.87
四、汇率变动对现金及现金等价物的影响-25,487,758.21-4,105,233.672,366,523.9924,824,735.62
五、现金及现金等价物净增加额2,876,824,963.683,497,809,332.125,449,886,504.9172,185,150.2
  加:期初现金及现金等价物余额5,185,964,713.125,185,964,713.125,185,964,713.125,013,779,562.92
  期末现金及现金等价物余额8,062,789,676.88,683,774,045.2410,635,851,218.025,185,964,713.12
补充资料:
  净利润-284,191,771.38-474,589,331.67
  资产减值准备-57,703,425.03-87,320,261.39
  固定资产和投资性房地产折旧-147,637,368.92-301,056,549.77
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-147,637,368.92-301,056,549.77
  无形资产摊销-10,069,842.78-20,101,234.17
  长期待摊费用摊销-1,837,346.18-4,303,229.92
  处置固定资产、无形资产和其他长期资产的损失--5,186,013--403,263.87
  固定资产报废损失---35,149.7
  公允价值变动损失--2,172,228.69--
  财务费用-15,399,686.47--350,771.65
  投资损失-5,951,887.58-8,951,802.66
  递延所得税--28,638,050.83--51,490,781.23
  其中:递延所得税资产减少--28,963,885.14--51,490,781.23
    递延所得税负债增加-325,834.31--
  存货的减少--39,253,099.97-198,507,079.25
  经营性应收项目的减少--159,953,837.79--246,248,690.98
  经营性应付项目的增加-41,731,786.3-22,482,465.51
  其他-3,099,205.14--1,264,832.41
  现金的期末余额-8,683,774,045.24-5,185,964,713.12
  减:现金的期初余额-5,185,964,713.12-5,013,779,562.92
  现金及现金等价物的净增加额-3,497,809,332.12-172,185,150.2
公告日期2025-10-312025-08-162025-04-302025-04-22
审计意见(境内)标准无保留意见
TOP↑